4.4 Review

Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: a systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Geriatrics & Gerontology

Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with Worse Outcomes in Dementia

Delia Bishara et al.

Summary: The study found that urinary drugs with high central anticholinergic burden, such as tolterodine and oxybutynin, were associated with a 55% increased risk of mortality in dementia patients, compared to drugs with low or no central anticholinergic burden like darifenacin, fesoterodine, trospium, mirabegron, solifenacin.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

Review Urology & Nephrology

The cognitive effect of anticholinergics for patients with overactive bladder

Blayne Welk et al.

Summary: Overactive bladder (OAB) is commonly treated with anticholinergic medications, which may affect cognitive function in the short term and potentially increase the risk of dementia in the long term. Careful consideration of cognitive impairment risk factors and related factors is important when selecting anticholinergic agents for OAB treatment.

NATURE REVIEWS UROLOGY (2021)

Article Urology & Nephrology

Onabotulinumtoxin A (Botox): A reasonable alternative for refractory neurogenic bladder dysfunction in children and young adults

Kenneth A. Softness et al.

Summary: The study aimed to evaluate the effectiveness of Botox in children with neurogenic bladder unresponsive to medical therapy and identify urodynamic parameters predictive of success. Results showed that a subset of patients had clinical success with Botox treatment, with differential improvements in capacity and compliance based on baseline urodynamic parameters.

NEUROUROLOGY AND URODYNAMICS (2021)

Article Environmental Sciences

Cost-Utility Analysis of Oxybutynin vs. OnabotulinumtoxinA (Botox) in the Treatment of Overactive Bladder Syndrome

Habiba Shabir et al.

Summary: The study found that using Botox as a first-line treatment for overactive bladder syndrome was more cost-effective, particularly for adults, but less cost-effective for younger patients. This suggests the need for further research to determine the age at which Botox becomes cost-effective in the management of OAB.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Medicine, General & Internal

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study

Carol A. C. Coupland et al.

JAMA INTERNAL MEDICINE (2019)

Article Urology & Nephrology

EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence

Arjun K. Nambiar et al.

EUROPEAN UROLOGY (2018)

Article Urology & Nephrology

Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology

Jan Groen et al.

EUROPEAN UROLOGY (2016)

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Review Urology & Nephrology

Intravesical oxybutynin for children with poorly compliant neurogenic bladder: A systematic review

Luis Antonio Guerra et al.

JOURNAL OF UROLOGY (2008)

Article Urology & Nephrology

The effects of anticholinergic drugs on attention span and short-term memory skills in children

Karla M. Giramonti et al.

NEUROUROLOGY AND URODYNAMICS (2008)

Article Pediatrics

The neurogenic bladder: medical treatment

Carla Verpoorten et al.

PEDIATRIC NEPHROLOGY (2008)

Article Urology & Nephrology

Myelomeningocele in young adults

CRJ Woodhouse

BJU INTERNATIONAL (2005)

Article Urology & Nephrology

Intravesical oxybutynin: A local anesthetic effect on bladder C afferents

S De Wachter et al.

JOURNAL OF UROLOGY (2003)

Article Urology & Nephrology

Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity

K Lehtoranta et al.

SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2002)

Article Urology & Nephrology

Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies

W Schafer et al.

NEUROUROLOGY AND URODYNAMICS (2002)

Article Pediatrics

Bladder-sphincter dysfunction in myelomeningocele

JD van Gool et al.

EUROPEAN JOURNAL OF PEDIATRICS (2001)

Article Urology & Nephrology

Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida

P Ferrara et al.

BJU INTERNATIONAL (2001)